+44 (0)1223 727114 firstname.lastname@example.org
Wednesday 14th November, 2012
Synoptics Health, a new division of Synoptics, a world leader in the development and manufacture of innovative digital imaging systems for scientific applications, is delighted to announce the appointment of Peskett Solutions Ltd. as its exclusive UK and Ireland distribution partner for ProReveal, an ultra sensitive fluorescent test for detecting protein contamination on surgical instruments.
Under the terms of the agreements, Peskett Solutions will market and support Synoptics Health’s new ProReveal Test. The test consists of a ProReveal Protein Detection Test Kit, which conforms to BS EN ISO 15883-1 and a ProReveal Viewer, which when used in combination will detect nanogram amounts of fluorescent proteins on surgical instruments.
This new ProReveal Test aligns with the recommendations of the new NHS CFPP-01-01 consultation document. In independent trials at sterile services departments (SSDs) in two major London hospitals the ProReveal Test achieved a 100-fold increase in sensitivity of protein detection, compared to current protein detection tests used in SSDs.
Matthew Peskett, Managing Director of Peskett Solutions explained: “We saw the ProReveal technology being developed by Synoptics Health in collaboration with Queen Mary University of London and were amazed by how easily it could detect where protein contamination is located on a surgical instrument. Current protein tests don’t really tell you where the protein is on an instrument and in an SSD, knowing where the protein is, can help you pin-point if and where, the issues lie with your decontamination process, and this is where ProReveal will provide a major benefit.”
Peskett added: “We were also impressed that the ProReveal Protein Detection Test Kit combined sensitivity and affordability. We believe that ProReveal will be a real advance for decontamination testing and this is why we’re very excited to be chosen as UK distributors of this innovative technology.”
Paul Ellwood, CEO of Synoptics Health commented: “We are delighted to be partnering with such a well-respected decontamination company to help us support our ProReveal Test. Peskett Solutions has an extensive network of professionals with SSD expertise and this will make it quicker and easier for decontamination professionals to implement the ProReveal technology into their facility, confident that they will have expert guidance in their transition to a more sensitive and cost-effective protein decontamination testing method.”